Skip to main content

Advertisement

Table 3 All grade (left column) and grade 3/4 (right column) treatment-related toxicities at final analysis (n = 43)

From: Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

Toxicity All grade Grade 3-4
non-hematological
  Fatigue 32.4% 0.1%*
  Nausea 8.0% 0%
  Vomiting 5.0% 0%
  Diarrhea 10.5% 0.1%*
  Mucositis 4.5% 0.1%*
  Sensorial neuropathy 2.4% 0%
hematological
  Anemia 44.0% 0.1%*
  Leukopenia 3.2% 0%
  Neutropenia 4.0% 0.1%*
  1. *Rounded to 0.1%.